Search for Clinical Trials
Patients may be considered if the cancer has come back, has not gone away after standard treatment or the patient cannot receive standard treatment.…
Phase I study of HER2 chimeric antigen receptor (CAR) T cells in combination with checkpoint blockade in patients with advanced sarcoma (HEROS 3.0)…
This research study uses special immune system cells called AGAR T cells, a new experimental treatment.
The purpose of this study is to learn more about how changes in DNA sequence (called genetic mutations) affect a person's chances of developing…
